A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

Clinical trial NCT06342713 · COMPLETED

Trial details

NCT number: NCT06342713
Sponsor: BeiGene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants Healthy Subjects Healthy Volunteers Autoimmune Diseases Healthy Adult Participants Atopic Dermatitis Prurigo Nodularis

Start date: 2024-06-20
Primary completion: 2026-06-02
Enrollment: 203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.